Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Dec;130(3):548-56.
doi: 10.1046/j.1365-2249.2002.02017.x.

Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis

Affiliations

Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis

H Fujii et al. Clin Exp Immunol. 2002 Dec.

Abstract

In patients with systemic sclerosis (SSc), there are conflicting findings regarding which is predominant between type 1 and type 2 immune responses. To determine the balance between type 1 and type 2 T lymphocytes in peripheral blood from SSc patients, we investigated the expression of intracellular cytokines, such as interferon-gamma (IFN-gamma), interleukin-2 (IL-2), IL-4, and IL-13, and chemokine receptors such as CXCR3 and CCR4 by flow cytometry. The frequency of IFN-gamma-producing cells among CD8+ cells was significantly increased in patients with diffuse cutaneous SSc (n = 11, P < 0.0001) and limited cutaneous SSc (lSSc; n= 16, P < 0.0001) compared with normal controls (n = 17) while there was no significant difference in the frequency of IL-4- or IL-13-producing cells. In contrast, the frequency of IFN-gamma- or IL-4-producing cells among CD4+ cells was similar between the three groups. Similar results were obtained when absolute numbers were assessed. The frequency of IFN-gamma-producing cells among CD8+ cells inversely correlated with percentage DLco in SSc patients (r = - 0.650, P < 0.005). CXCR3+ CD8+ cells selectively produced IFN-gamma, and the frequency of CXCR3+ CD45RO+ cells among CD8+ cells was higher in lSSc patients (n = 14, P < 0.01) than in normal controls (n = 22). In contrast, there was no significant difference in the frequencies of CXCR3- or CCR4-expressing CD45RO+ cells among CD4+ cells. These results demonstrate the predominance of type 1 cytokine-producing cells (Tc1 cells) in peripheral blood CD8+ T cells from SSc patients, but no definite Th1/Th2 imbalance in CD4+ T cells. Tc1 cells may be associated with pulmonary vascular damage in SSc.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Representative expression of IFN-γ and IL-4 in the cytoplasm of CD8+ and CD8 (CD4+) T cells from a patient with diffuse cutaneous systemic sclerosis (dSSc), a patient with limited cutaneous SSc (lSSc), and a normal control (control). Whole blood samples were activated with phorbol myristate acetate and ionomycin in the presence of brefeldin A. Intracellular cytokine production was determined by flow cytometry with three-colour analysis. Plots represent live cells gated for expression of CD3. Quadrants were set according to the staining of control MoAbs.
Fig. 2
Fig. 2
Frequencies of CD8+ T cells producing (a) IFN-γ, (b) IL-2, (c) IL-4 and (d) IL-13 in peripheral blood CD8+ T cells from dSSc patients, lSSc patients, and normal controls (control). Intracellular expression of cytokines was determined by flow cytometry, as described in Fig. 1. Bars indicate the medians.
Fig. 3
Fig. 3
Frequencies of CD4+ T cells producing (a) IFN-γ, (b) IL-2, (c) IL-4 and (d) IL-13 in peripheral blood CD4+ T cells from dSSc patients, lSSc patients, and normal controls (control). Intracellular expression of cytokines was determined by flow cytometry, as described in Fig. 1. Bars indicate the medians.
Fig. 4
Fig. 4
The inverse relation between the frequency of IFN-γ-producing cells among peripheral blood CD8+ T cells and percentage DLco in SSc patients. Intracellular expression of IFN-γ was determined by flow cytometry, as described in Fig. 1. r =−0·650; P < 0·005
Fig. 5
Fig. 5
Representative expression of IFN-γ and IL-4 in the cytoplasm of CXCR3+ CD8+ T cells in peripheral blood from (a) a patient with SSc and (b) a normal control. Whole blood samples were activated with phorbol myristate acetate and ionomycin in the presence of brefeldin A. Intracellular cytokine production was determined by flow cytometry with three-colour analysis. Histograms represent live cells gated for expression of CD8 and CXCR3 (——). Staining of control MoAbs (------).
Fig. 6
Fig. 6
Frequencies of CCR4+ or CXCR3+ cells in peripheral blood CD8+ or CD4+ memory T cells from dSSc patients, lSSc patients, and normal controls (control). CCR4 and CXCR3 expression was determined by flow cytometry with three-colour analysis. Bars indicate the medians.

References

    1. Gruschwitz M, Sepp N, Kofler H, Wick G. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Immunobiology. 1991;182:234–55. - PubMed
    1. Gruschwitz M, von den Vieth G. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage. Arthritis Rheum. 1997;40:540–50. - PubMed
    1. Gruschwitz M, von den Driesch P, Kellner I, Hornstein OP, Sterry W. Expression of adhesion proteins involved in cell-cell and cell–matrix interactions in the skin of patients with progressive systemic sclerosis. J Am Acad Dermatol. 1992;27:169–77. - PubMed
    1. Sollberg S, Peltonen J, Uitto J, Jimenez SA. Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum. 1992;35:290–8. - PubMed
    1. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol. 1992;166:255–63. - PubMed

MeSH terms